Osaic Holdings’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.5K | Sell |
12,427
-5,520
| -31% | -$14.4K | ﹤0.01% | 5006 |
|
2025
Q1 | $22.1K | Buy |
17,947
+9,412
| +110% | +$11.6K | ﹤0.01% | 5258 |
|
2024
Q4 | $26.5K | Buy |
8,535
+1,450
| +20% | +$4.51K | ﹤0.01% | 5111 |
|
2024
Q3 | $20K | Hold |
7,085
| – | – | ﹤0.01% | 5341 |
|
2024
Q2 | $38.5K | Sell |
7,085
-1,500
| -17% | -$8.15K | ﹤0.01% | 4855 |
|
2024
Q1 | $36.9K | Buy |
8,585
+2,200
| +34% | +$9.46K | ﹤0.01% | 4929 |
|
2023
Q4 | $35.1K | Sell |
6,385
-4,027
| -39% | -$22.1K | ﹤0.01% | 5120 |
|
2023
Q3 | $47.3K | Buy |
10,412
+5,965
| +134% | +$27.1K | ﹤0.01% | 5032 |
|
2023
Q2 | $13.8K | Sell |
4,447
-3,018
| -40% | -$9.36K | ﹤0.01% | 5763 |
|
2023
Q1 | $5.3K | Buy |
7,465
+66
| +0.9% | +$47 | ﹤0.01% | 6237 |
|
2022
Q4 | $20.6K | Buy |
7,399
+2,778
| +60% | +$7.75K | ﹤0.01% | 5537 |
|
2022
Q3 | $17K | Sell |
4,621
-200
| -4% | -$736 | ﹤0.01% | 5693 |
|
2022
Q2 | $16K | Sell |
4,821
-100
| -2% | -$332 | ﹤0.01% | 5755 |
|
2022
Q1 | $22K | Buy |
4,921
+929
| +23% | +$4.15K | ﹤0.01% | 5611 |
|
2021
Q4 | $38K | Sell |
3,992
-479
| -11% | -$4.56K | ﹤0.01% | 5335 |
|
2021
Q3 | $76K | Sell |
4,471
-690
| -13% | -$11.7K | ﹤0.01% | 4766 |
|
2021
Q2 | $144K | Buy |
5,161
+3,195
| +163% | +$89.1K | ﹤0.01% | 4166 |
|
2021
Q1 | $44K | Buy |
+1,966
| New | +$44K | ﹤0.01% | 4956 |
|